Zenith Capital Valuation Multiples
Discover revenue and EBITDA valuation multiples for Zenith Capital.
Zenith Capital Overview
About Zenith Capital
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary, which is a clinical-stage biotechnology company focused on discovering and developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders with unmet medical need. It is a epigenetic platform of biology and chemistry has generated differentiated, potent and selective BET inhibitors. Its goal is to be a epigenetic company translating bromodomain biology into impactful therapies.
Founded
2013
HQ
Employees
N/A
Website
Financials (FY)
EV
$16M
Valuation Multiples
Start free trial
Zenith Capital Financials
Zenith Capital reported last fiscal year revenue of - and negative EBITDA of ($7M).
In the same fiscal year, Zenith Capital generated ($7M) in EBITDA losses and had net loss of ($8M).
Zenith Capital P&L
In the most recent fiscal year, Zenith Capital reported revenue of - and EBITDA of ($7M).
Zenith Capital is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Zenith Capital Stock Performance
Zenith Capital has current market cap of $16M, and enterprise value of $16M.
Market Cap Evolution
Zenith Capital's stock price is $0.10.
Zenith Capital has an EPS (earnings per share) of $-0.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16M | $16M | 400.0% | - | - | - | $-0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialZenith Capital Valuation Multiples
Zenith Capital trades at (2.2x) EV/EBITDA.
Zenith Capital Financial Valuation Multiples
As of August 20, 2026, Zenith Capital has market cap of $16M and EV of $16M.
Zenith Capital has a P/E ratio of (2.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Zenith Capital Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Zenith Capital Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Zenith Capital competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Zenith Capital
| When was Zenith Capital founded? | Zenith Capital was founded in 2013. |
| Where is Zenith Capital headquartered? | Zenith Capital is headquartered in Canada. |
| Is Zenith Capital publicly listed? | Yes, Zenith Capital is a public company listed on OTCM. |
| What is the stock symbol of Zenith Capital? | Zenith Capital trades under ZHCLF ticker. |
| When did Zenith Capital go public? | Zenith Capital went public in 2020. |
| Who are competitors of Zenith Capital? | Zenith Capital main competitors include |
| What is the current market cap of Zenith Capital? | Zenith Capital's current market cap is $16M. |
| Is Zenith Capital profitable? | No, Zenith Capital is not profitable. |
| How many companies Zenith Capital has acquired to date? | Zenith Capital hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Zenith Capital has invested to date? | Zenith Capital hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Zenith Capital
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.